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Edited by Felix WielandAbstract Targeted positioning of water channel aquaporin-2
(AQP2) strictly regulates body water homeostasis. Traﬃcking of
AQP2 to the apical membrane is critical to the reabsorption
of water in renal collecting ducts. Controlled apical positioning of
AQP2 suggests the existence of proteins that interact with
AQP2. A biochemical search for AQP2-interacting proteins led
to the identiﬁcation of PDZ-domain containing protein, signal-
induced proliferation-associated gene-1 (SPA-1) which is a
GTPase-activating protein (GAP) for Rap1. The distribution of
SPA-1 coincided with that of AQP2 in renal collecting ducts. The
site of colocalization was concomitantly relocated by hydration
status. AQP2 traﬃcking to the apical membrane was inhibited by
the SPA-1 mutant lacking Rap1GAP activity and by the
constitutively active mutant of Rap1. AQP2 traﬃcking was
impaired in SPA-1-deﬁcient mice. Our results show that SPA-1
directly binds to AQP2 and regulates at least in part AQP2
traﬃcking.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Body water homeostasis is essential for survival of mam-
mals. Water transport occurs through specialized channels
called aquaporins (AQPs). AQPs play an important role in
reabsorption of water and in concentration of urine in the
kidney. At least seven diﬀerent AQPs exist in the kidney,
however, AQP2 is the only known water channel to be regu-* Corresponding author. Fax: +81-3-5803-5215.
E-mail address: ynodmed2@tmd.ac.jp (Y. Noda).
q Data deposition: GenBank Accession No. for the cDNA sequence
reported in this paper is AB091474.
Abbreviations: AQP2, aquaporin-2; MDCK cells, Madin–Darby
canine kidney cells; NDI, nephrogenic diabetes insipidus
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doi:10.1016/j.febslet.2004.05.021lated by antidiuretic hormone vasopressin [1,2]. The vaso-
pressin tightly regulates body water balance. The binding of
vasopressin to vasopressin V2 receptors on renal principal cells
stimulates cAMP synthesis via activation of adenylate cyclase.
The subsequent activation of protein kinase A (PKA) leads to
phosphorylation of AQP2 and this phosphorylation event is
required to increase the water permeability and water reab-
sorption of principal cells. In this process, subapical storage
vesicles in principal cells containing AQP2 translocate to and
fuse with the apical plasma membrane, rendering the cell water
permeable. Upon removal of vasopressin, AQP2 is internalized
by endocytosis into the storage vesicles that restore the water-
impermeable state of the cell. However, the molecular mech-
anism by which PKA phosphorylation of AQP2 facilitates this
transport process is unclear.
Controlled apical positioning of AQP2 suggests the existence
of proteins that recruit AQP2 by binding directly. To date,
several proteins which are localized in AQP2-bearing vesicles
and are supposed to mediate its sorting and exocytic insertion
have been reported (e.g., Rab proteins, soluble NSF attach-
ment protein receptors (SNAREs), and cytoskeletal proteins)
[1], however, proteins that directly interact with AQP2
and provide speciﬁcity in AQP2 sorting have not yet been
identiﬁed.
Mutations in human AQP2 or downregulation of AQP2
expression cause hereditary or acquired nephrogenic diabetes
insipidus (NDI), a disease characterized by a massive loss of
water through the kidney [1]. In addition, AQP2-T126M
knock-in mice with impaired AQP2 traﬃcking have severe
NDI with neonatal mortality [3]. Recently, AQP2 mutations
with dominant-type NDI showed the importance of C termi-
nus of AQP2 for its traﬃcking [4–6]. Interestingly, the C-ter-
minal sequences of human, mouse and rat AQP2 (Gly–Thr/
Ser–Lys–Ala) match to the class I PDZ-interacting motif (X–
Thr/Ser–X–U) (X, unspeciﬁed amino acid; U, hydrophobic
amino acid) [7]. It is well known that PDZ-domain containing
proteins are involved in targeting, anchoring, and stabilizing of
membrane proteins. Therefore, we speculated the existence of
the proteins that interacted with AQP2 through a PDZ-
domain interaction.blished by Elsevier B.V. All rights reserved.
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protein which directly bound to AQP2 and regulated AQP2
traﬃcking.2. Materials and methods
2.1. Pull-down experiments
PDZ1 domain (amino acid residues (aa) 1–98) and PDZ2 domain
(aa 139–248) of EBP50 [8], the N-terminal region (aa 1–610), PDZ
domain (aa 685–760) and C-terminal region (aa 844–1040) of rat sig-
nal-induced proliferation-associated gene-1 (SPA-1) were subcloned
into pGEX-4T-1 (Amersham) to generate GST-fusion proteins.
C-terminal region of human AQP2 (aa 226–271 (AQP2CT)) was
subcloned into pQE40 (Qiagen) to generate dihydrofolate reductase
(DHFR)-fusion protein. DHFR was fused to the N-terminus of
AQP2CT. To generate AQP2CT(AAAA), the last four amino acids of
AQP2CT were substituted with four alanine residues. GST-fusion
proteins were expressed in Escherichia coli BL21(DE3). Each protein (5
lg) was immobilized on glutathione–Sepharose (Amersham) and was
combined with solubilized AQP2CT/DHFR proteins (10 lg) or
AQP2CT(AAAA)/DHFR proteins (10 lg) prepared from E. coli
M15(pREP4). Bound proteins were eluted by glutathione and analyzed
by Western blotting with an aﬃnity-puriﬁed rabbit antibody against C
terminus of AQP2 [9].Fig. 1. SPA-1 binding to AQP2. (A) Pull-down assays. AQP2CT/DHFR was
proteins were immunoblotted with anti-AQP2 antibody. The molecular mas
were indicated on the left. (B) Pull-down assays using GST/SPA-1-NT, GST
recognized equally both wild-type (AQP2CT) and mutant proteins (AQP2CT
1-NT, SPA-1-PDZ and SPA-1-CT is shown in under part. (C) Immunoblot a
extracts were immunoblotted with anti-SPA-1 antibody. (D) Coimmunopr
papillae were immunoprecipitated with anti-SPA-1 antibody, anti-AQP2 ant
panel) and SPA-1 (right panel), respectively. Inputs represent 10% of the lys2.2. Immunoscreening of cDNA library form rat kidney papilla
All animal experiments in this study were approved by the Institu-
tional Animal Care and Use Comittee of Tokyo Medical and Dental
University. Rat kidney papilla mRNA was isolated using mRNA
puriﬁcation kit (Amersham), and a cDNA expression library was
constructed in kTripleEx2 vector using cDNA library construction kit
(Clontech). Immunoscreening was performed using anti-PDZ1-EBP50
antibody [10] as described [11].
2.3. Immunoblot analysis of SPA-1
Tissues from rat kidney cortex and papilla were homogenized in a
solution containing 50 mM Tris–HCl, pH 7.4, 1 mM 2-mercap-
toethanol, and 1 mM EDTA. Madin–Darby canine kidney (MDCK)
cells were solubilized in lysis buﬀer containing 20 mM Tris–HCl, pH
7.4, 150 mM NaCl, and 1% NP-40. Each sample was analyzed by
Western blotting with anti-SPA-1 antibody [12].
2.4. Immunoprecipitation
Rat kidney papillae were homogenized in lysis buﬀer containing 20
mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5% Tween 20, 100 mM
3-isobutyl-1-methylxanthine, 10 mM b-glycerophosphate, 0.15 mM
sodium orthovanadate, 1 mM dithiothreitol, and an EDTA-free pro-
tease inhibitor mixture (Roche). The homogenates were spun at
20 000 g for 30 min and 500 ll (500 lg protein) of the supernatants
were incubated with anti-SPA-1 antibody or anti-AQP2 antibody.
Immunocomplex was precipitated with protein A–Sepharose andpulled down using each GST/PDZ1 and GST/PDZ2 of EBP50. Bound
s of AQP2CT/DHFR is 28.6 kDa. Molecular mass standards (in kDa)
/SPA-1-PDZ and GST/SPA-1-CT, respectively. Anti-AQP2 antibody
(AAAA)) (input control lysate lanes). Schematic representation of SPA-
nalysis of SPA-1 in rat kidney cortex, papilla, and MDCK cells. Tissue
ecipitation experiments of SPA-1 and AQP2. Extracts of rat kidney
ibody or normal IgG. Precipitates were immunoblotted for AQP2 (left
ates used for the immunoprecipitation reaction.
Fig. 2. Localization of AQP2 and SPA-1 in renal collecting ducts. Rats
were hydrated (A,B) or water-deprived (C,D) for 24 h. (A,C) Trans-
verse sections; (B,D) longitudinal sections through collecting duct tu-
bules. Left panels, immunolabelling of AQP2 (red); middle panels,
immunolabelling of SPA-1 (green); right panels, merged images of
AQP2 and SPA-1. Yellow indicates colocalization of AQP2 and SPA-
1. Scale bars: 50 lm. (E) Quantitative analyses for the translocation of
AQP2 and SPA-1 induced by dehydration. From the immunoﬂuores-
cence distributions of AQP2 and SPA-1 as shown above, the statistical
parameter of skewness was calculated. White bars (H) indicate the
values under hydrated conditions and black bars (D) indicate the
values under dehydrated conditions. Data represent means and S.E.
from 20 cells of two independent experiments. *P < 0:05.
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negative control. Cell extracts (50 lg protein) and immunoprecipitated
samples were analyzed by Western blotting with anti-AQP2 or anti-
SPA-1 antibody.
2.5. Immunohistochemistry in renal collecting ducts
For double immunolabelling of AQP2 and SPA-1, rat kidney was
ﬁxed with 4% paraformaldehyde in PBS, cryoprotected with 20%
sucrose in PBS, embedded in OCT compound, and frozen in liquid N2.
Cryostat sections were blocked with 3% goat serum in PBS and in-
cubated with anti-SPA-1 antibody followed by incubation with Alexa
488 anti-rabbit IgG (Molecular Probes). The sections were washed and
incubated with unlabelled goat anti-rabbit IgG. After washing, sec-
tions were incubated with anti-AQP2 antibody followed by incubation
with Alexa 546 anti-rabbit IgG. Immunoﬂuorescence images were
viewed with LSM 510 confocal microscope (Carl Zeiss). Control ex-
periments were performed with non-immune IgG for each primary
antibody, revealing no positive staining.
For immunolabelling of AQP2 in kidneys from SPA-1-deﬁcient mice
[13,14] and wild-type mice, the samples were stained by anti-AQP2
antibody and visualized by Alexa 488 anti-rabbit IgG.
2.6. Quantitative immunoﬂuorescence
To quantify the distribution of AQP2 and SPA-1 in collecting duct
cells, the immunoﬂuorescence intensities were analyzed using Scion
Image (Scion Corporation). At least three diﬀerent ﬁelds of the
coverslips were analyzed from two separate experiments for each
group. In each cell, the cytoplasmic area was marked on the diﬀeren-
tial-interference-contrast light micrographs. The distribution of pixel
intensity in the cytoplasmic area of each cell was determined by the
software and skewness was calculated. Skewness is a measure of
symmetry of a proﬁle about the mean pixel intensity.
2.7. Transfection and cell surface labelling of AQP2
LIG–SPA-1 mutant, which lacked Rap1GAP activity [15,16], was
generated by mutating RKR residues (aa 420–422) of SPA-1 to LIG
using site-direct mutagenesis kit (Stratagene). Flag epitope tag was
introduced at the N-terminal end of the mutant. Rap1 mutants were
produced from the corresponding cDNA by replacement of glycine
with valine at position 12 (Rap1V12) and by substitution of serine for
asparagine at position 17 (Rap1N17), respectively. T7 epitope tag was
introduced at the N-terminal end of each mutant. The constructs were
subcloned in pcDL-SRa296.
MDCK cells stably expressing AQP2 proteins (MDCK/AQP2) [17]
were cultured in DMEM supplemented with 10% fetal bovine serum,
100 U/ml of penicillin, 100 lg/ml of streptomycin, and 700 lg/ml of
G418 (Sigma). The cells grown on permeable ﬁlter supports (Corning)
were transiently transfected with these mutants using LipofectAMINE
2000 (Invitrogen). The cells were stimulated with 40 nM forskolin for
30 min. In Rap1N17 transfected cells, H89 (ﬁnal concentration 30 lM;
Seikagaku Corporation, Tokyo) was added to the medium for 30 min
before the forskolin treatment. The cells were ﬁxed with 4% parafor-
maldehyde, blocked with 1% BSA in PBS, incubated with rabbit an-
tibody against the external C-loop of AQP2 raised using an
oligopeptide (aa 113–127) [2], and incubated with Alexa 488 anti-
rabbit IgG antibody. The cells were then permeabilized with 0.1%
Triton X-100 and blocked with 2% BSA and 10% goat serum in PBS.
The cells transfected with LIG–SPA-1 were incubated with anti-Flag
M2 antibody (Sigma), and the cells transfected with Rap1V12 and
Rap1N17 were incubated with anti-T7 antibody (Novagen), respec-
tively. The cells in each experiment were then incubated with Alexa 568
anti-mouse IgG antibody.
2.8. Adenovirus-mediated Rap1V12 expression and immunolabelling for
surface-localized AQP2
MDCK/AQP2 cells were infected with adeno/GFP-Rap1V12 [18].
The cells were treated with 40 nM forskolin for 30 min and ﬁxed with
4% paraformaldehyde. Apical localized AQP2 was immunolabelled as
described above and visualized with Alexa 546 anti-rabbit IgG anti-
body. For double immunolabelling of AQP2 and Naþ/Kþ-ATPase, the
cells were treated with 0.1% Triton X-100 and incubated with rabbit
antibody against C-terminus of AQP2 followed by incubation with
Alexa 488 anti-rabbit IgG antibody. After washing, sections were
incubated with chicken antibody against canine Naþ/Kþ-ATPase
(Abcam) and then with Alexa 594 anti-chicken IgG antibody.2.9. Cell surface biotinylation
Apical cell surface labelling was performed as described [19] except
the lysis buﬀer (150 mM NaCl, 50 mM Tris–HCl, pH 7.5, 5 mM
EDTA, 1% NP-40, 0.1% SDS, 0.5% deoxycholate and protease
inhibitor mixture). Quantiﬁcation of the bands was performed using
Scion Image.
2.10. Statistical analyses
Statistical analyses were made using unpaired Student’s t test.
Diﬀerences were considered signiﬁcant at P value less than 0.05.3. Results
3.1. Identiﬁcation of AQP2-binding protein
To examine whether the C-terminus of AQP2 (AQP2CT)
interacts with PDZ domains, we performed pull-down assays
using GST-fusion proteins containing either of the two PDZ
domains of EBP50, an epithelium-speciﬁc scaﬀolding protein
[8]: PDZ1 (aa 1–98) or PDZ2 (aa 139–248) (Fig. 1A). AQP2CT
Fig. 3. Surface labelling for AQP2 in each LIG–SPA-1, Rap1V12, and
Rap1N17-transfected MDCK/AQP2 cells. (A) MDCK/AQP2 cells
transfected with Flag-LIG–SPA-1 were treated without (upper panels)
or with (lower panels) forskolin. The cells were double-labelled for
Flag-LIG–SPA-1 (left panels, red) and surface-localized AQP2 (middle
panels, green), and merged in right panels. (B) MDCK/AQP2 cells
transfected with T7-Rap1V12 were treated without (upper panels) or
with (lower panels) forskolin. The cells were double-labelled for
T7-Rap1V12 (left panels, red) and surface-localized AQP2 (middle
panels, green), and merged in right panels. (C) MDCK/AQP2 cells
transfected with T7-Rap1N17 were left untreated (upper panels) or
pretreated with H89, a PKA inhibitor, before incubation with for-
skolin (lower panels). The cells were double-labelled for T7-Rap1N17
(left panels, red) and surface-localized AQP2 (middle panels, green),
and merged in right panels. Scale bars: 10 lm.
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did not bind to GST alone, indicating that AQP2 might in-
teract with proteins containing a PDZ1-like sequence. To
isolate such proteins, we performed an immunoscreening of rat
kidney papilla cDNA expression library using antibody
against PDZ1 domain, because AQP2 was expressed abun-
dantly in papilla [2]. From 1.4 106 independent recombi-
nants, three positive clones were isolated. These clones
encoded partial polypeptide fragments derived from the same
protein. The deduced amino acid sequence from the complete
nucleotide sequence encoded a polypeptide of 1040-amino
acids. The protein shows extremely high overall homology to
mouse SPA-1 (96%) and to human SPA-1 (89%), respectively
[12]. These ﬁndings indicate that the protein deduced from our
cDNA is the rat counterpart of SPA-1. To examine whether
SPA-1 binds speciﬁcally to the C-terminus of AQP2
(AQP2CT), we performed pull-down assays using N-terminal
region (aa 1–610: SPA-1-NT), PDZ domain (aa 685–760: SPA-
1-PDZ) and C-terminal region (aa 844–1040: SPA-1-CT) of
SPA-1 expressed as GST-fusion proteins (Fig. 1B). Both GST/
SPA-1-PDZ and GST/SPA-1-CT interacted with AQP2CT.
GST/SPA-1-NT and GST alone did not bind to AQP2CT. In
contrast to SPA-1-PDZ, SPA-1-CT did not contain a typical
sequence of PDZ domain. It is supposed that SPA-1-CT may
mimic a conformational similarity to a PDZ domain. Substi-
tution of the last four amino acids of AQP2CT with four
alanine residues (AQP2CT(AAAA)) abrogated these two in-
teractions. This ﬁnding shows the signiﬁcance of the C-termi-
nus of AQP2 for the interaction with SPA-1.
To examine the existence of SPA-1 in the kidney, immuno-
blots were performed using tissue extracts from rat kidney
cortex and papilla, respectively (Fig. 1C left panel). SPA-1 was
obviously detected in papilla and faintly in cortex. SPA-1 was
also detected in cultured MDCK cells (Fig. 1C, right panel).
To verify the endogenous interaction of SPA-1 and AQP2 in
the kidney papilla, we performed coimmunoprecipitation as-
says (Fig. 1D). From the tissue extracts of rat papilla, AQP2
was coimmunoprecipitated with anti-SPA-1 antibody and
SPA-1 was also coimmunoprecipitated with anti-AQP2 anti-
body, respectively. On the contrary, AQP2 and SPA-1 were
not immunoprecipitated with normal IgG. Coimmunoprecip-
itation analysis showed that endogenous AQP2 and SPA-1
proteins formed a complex in the kidney papilla.
3.2. SPA-1 colocalizes with AQP2 in renal collecting ducts
To examine whether SPA-1 controls AQP2 sorting, we
performed immunohistochemistry for SPA-1 and AQP2 in the
kidney papilla (Fig. 2). In hydrated rats, AQP2 was localized
predominantly in the intracellular vesicles of renal collecting
duct principal cells (Fig. 2A and B, left panels). Water depri-
vation accumulated AQP2 in the apical region of the cells
(Fig. 2C and D, left panels). The distribution of SPA-1 was
also changed by water balance alteration. In hydrated rats,
SPA-1 was localized predominantly in the intracellular vesicles
(Fig. 2A and B, middle panels). Water-deprivation increased
the accumulation of SPA-1 labelling in the apical region
(Fig. 2C and D, middle panels). Double immunolabelling of
AQP2 and SPA-1 revealed colocalization of the two proteins
in the apical region of collecting duct cells upon water-depri-
vation and in the intracellular vesicles upon hydration,
respectively (Fig. 2A–D, right panels). These ﬁndings strongly
suggest that AQP2 and SPA-1 are simultaneously regulated bywater balance and SPA-1 may be involved in recruitment of
AQP2 to the targeted site.
To conﬁrm the translocation of the two proteins quantita-
tively, we calculated skewness of these signal intensity distri-
butions (Fig. 2E). A random pixel intensity distribution is
characterized by a low value in skewness, whereas most pixels
concentrated in a narrow range are characterized by a high
value in skewness. Under hydrated conditions AQP2 was
distributed randomly and skewness was 1.84 0.11, whereas
under dehydrated conditions the value signiﬁcantly increased
Y. Noda et al. / FEBS Letters 568 (2004) 139–145 143(2.62 0.20, P < 0:05). Water-deprivation also increased sig-
niﬁcantly the value of SPA-1 distribution compared to that
under hydrated conditions (2.72 0.21 versus 2.18 0.13,
P < 0:05). These results indicate that SPA-1 is relocated by
hydration status in a manner similar to AQP2 translocation.
3.3. AQP2 traﬃcking is regulated by Rap1 signalling
SPA-1 is a GTPase-activating protein (GAP) for Rap1 and
inactivates Rap1 [12]. To assess the role of SPA-1 in AQP2
traﬃcking, we examined the eﬀect of dominant-negative mu-
tant LIG–SPA-1 which lacked GAP activity on AQP2 locali-
zation in the MDCK/AQP2 cells [17] (Fig. 3A). In the cells
transfected with LIG–SPA-1 (red), cell surface labelling of
AQP2 was decreased as compared to the untransfected cells
under the basal condition. Forskolin treatment increased
AQP2 translocation to the cell surface in the untransfected
cells, however, the surface delivery of AQP2 was still inhibitedFig. 4. Rap1V12 inhibits AQP2 translocation to the apical membrane. (A–
(A,B) were treated without (A,C) or with (B,D) forskolin and were labelled f
ﬂuorescence for GFP-Rap1V12, middle panels show red for surface-localized
sections from apical surface of the cells and each lower strip represents xz sca
shows distribution of red ﬂuorescence for apical-localized AQP2 along the u
labelled with antibody against C terminus of AQP2 (left panel, green) and an
panel. (F) MDCK/AQP2 cells expressing GFP-Rap1V12 (green, left panel) we
the overlay image. Scale bar in F is 10 lm that is applied to other panels. (G) M
above were subjected to a cell surface biotinylation assay. Biotinylated prot
lotted for AQP2. (H) Summary of quantitative densitometry expressed as a
AQP2 cells without forskolin incubation. Data represent means and S.E. froby this treatment in the mutant transfected cells. These ﬁnd-
ings show that GAP activity of SPA-1 is important for AQP2
traﬃcking.
Next, we examined the contribution of Rap1 signalling to
AQP2 traﬃcking. In the cells transfected with Rap1V12 (red),
which was a constitutively active mutant, the surface expres-
sion of AQP2 was also decreased as compared to the un-
transfected cells with or without forskolin stimulation
(Fig. 3B). These ﬁndings show that increase in active form of
Rap1 impairs the surface delivery of AQP2.
On the other hand, in the cells transfected with dominant
negative mutant Rap1N17 (red), the cell surface labelling of
AQP2 increased as compared to the untransfected cells
(Fig. 3C). Pretreatment with H89, a speciﬁc PKA inhibitor,
abolished the forskolin-induced translocation of AQP2 in the
untransfected cells, however, the highly positive signals of cell
surface labelling of AQP2 were observed in Rap1N17 trans-D) MDCK/AQP2 cells either expressing GFP-Rap1V12 (C,D) or not
or surface-localized AQP2 (red). Right panels of C and D show green
AQP2, and left panels show the overlay images. The xy planes show
n at the position indicated by the black arrowhead on the right. xz scan
pper surface (apical membrane). (E) MDCK/AQP2 cells were double-
ti-Naþ/Kþ-ATPase antibody (middle panel, red), and merged in right
re labelled for Naþ/Kþ-ATPase (middle panel, red). Right panel shows
DCK/AQP2 cells either expressing GFP-Rap1V12 or not as described
eins were precipitated with streptavidin-agarose beads and immunob-
veraged relative levels normalized to 1.0 for non-transfected MDCK/
m three independent experiments. *P < 0:05.
144 Y. Noda et al. / FEBS Letters 568 (2004) 139–145fected cells. This ﬁnding shows that Rap1N17 suppresses the
endogenous Rap1 activity and increases the AQP2 traﬃcking
to the cell surface.
To conﬁrm the role of Rap1 signalling in AQP2 traﬃcking,
we used adenovirus vector for eﬃcient and homogeneous ex-
pression of Rap1V12 (Fig. 4). Under the basal condition,
apical labelling of AQP2 in Rap1V12-expressing cells was
decreased as compared to the control cells (Fig. 4A and C).
Although forskolin treatment increased AQP2 translocation to
the apical membrane in the control cells, the apical delivery of
AQP2 was still inhibited by this treatment in Rap1V12-
expressing cells (Fig. 4B and D). The staining pattern of a
basolateral marker, Naþ/Kþ-ATPase was not changed by
Rap1V12, indicating that Rap1V12 did not aﬀect the cell po-
larity (Fig. 4E and F). To quantify the eﬀect of Rap1V12 on
the AQP2 translocation to the apical surface, a cell surface
biotinylation assay was performed (Fig. 4G and H). Expres-
sion of Rap1V12 did not alter the total amount of AQP2 in the
cells. Apical localized AQP2 in Rap1V12-expressing cells un-
der the basal conditions was signiﬁcantly decreased compared
to that in the control cells (0.38 0.20 versus 1, P < 0:05).
Under forskolin stimulation, apical expression of AQP2 was
also decreased signiﬁcantly compared to that in the control
cells (0.59 0.24 versus 1.57 0.25, P < 0:05). These results
conﬁrm that AQP2 traﬃcking is inhibited by Rap1 activation.
3.4. SPA-1 deﬁciency impairs AQP2 traﬃcking
To examine the contribution of SPA-1 to the AQP2 traf-
ﬁcking in vivo, we performed immunohistochemistry for
AQP2 in renal collecting duct principal cells in SPA-1-deﬁcient
mice [13,14] under water-deprivation (Fig. 5A–D). Contrary to
the wild-type mice, AQP2 was not restricted to the apical re-
gion and diﬀusely distributed in the cytoplasm in the knockout
mice. To quantify the distribution of AQP2, skewness was
calculated from the immunoﬂuorescence distribution of AQP2
(Fig. 5E). Skewness value in knockout mice was signiﬁcantly
reduced compared to that in wild-type mice (1.23 0.42 versus
1.79 0.093, P < 0:001). These results conﬁrm that AQP2Fig. 5. Localization of AQP2 in the renal medulla of SPA-1-deﬁcient mice
mice. (A,C) Transverse sections; (B,D) longitudinal sections through collec
distribution of AQP2 in SPA-1-deﬁcient mice ()/)) and wild-type mice (+/+
calculated. Data represent means and S.E. from 40 cells of two independenttranslocation induced by water-deprivation is impaired in the
knockout mice.4. Discussion
Apical localization of AQP2 carries out water reabsorption
in renal collecting ducts. Misrouting of AQP2 is considerably
important in the pathophysiology of water balance disorders
including NDI. In the present experiments, we have discovered
the protein that regulates AQP2 sorting by binding directly.
To date, several proteins involved in AQP2 sorting have
been reported [1]. SNARE proteins are involved in the process
of docking and fusion of AQP2-containing vesicles to the
apical membrane. A complex of dynein and dynactin, which is
expected to be involved in the movement of vesicles toward the
apical membrane, associates with AQP2-bearing vesicles. In
spite of these reports, proteins that directly interact with AQP2
and provide speciﬁcity in AQP2 sorting have not yet been
clariﬁed.
In this study, we have successfully identiﬁed the AQP2-
binding protein, SPA-1. Biochemical and histochemical anal-
yses show that SPA-1 directly binds to AQP2 and regulates the
traﬃcking of AQP2 to the apical membrane. It is known that
there are several SPA-1-related proteins with similar functions
[20,21]. Among these proteins only SPA-1 was isolated from
rat kidney papilla cDNA expression library, indicating that
SPA-1 might play a major role in AQP2 traﬃcking in renal
collecting ducts. However, we cannot exclude the possibility
that SPA-1-related proteins may also be involved in AQP2
traﬃcking like SPA-1.
SPA-1 is a GAP for Rap1 [12,22]. Rap1 is a Ras-related
small GTPase and is implicated in many cellular processes
including regulation of Ras/ERK signalling pathway, cell
morphogenesis and cell diﬀerentiation [20]. Rap1 may also be
required for cytoskeletal organization through the crosstalk
with other small GTPases, including Ral and Rho [22]. It has
been recently reported that Rap1 GTPases are critical forunder water deprivation. (A,B) SPA-1-deﬁcient mice; (C,D) wild-type
ting duct tubules. Scale bar: 50 lm. (E) Quantitative analysis for the
). From the immunoﬂuorescence distribution of AQP2 skewness was
experiments. *P < 0:001 compared with wild-type mice.
Y. Noda et al. / FEBS Letters 568 (2004) 139–145 145vesicle traﬃcking [23]. These ﬁndings support our suggested
mechanism that SPA-1, a GAP for Rap1, is involved in
membrane protein sorting.
In addition, it is reported that RhoGTP prevents AQP2
translocation to the apical membrane by stimulating F-actin
polymerization [24,25]. In the present study, we have shown
that GAP activity of SPA-1 is required for AQP2 traﬃcking.
We are tempting to speculate that Rap1 aﬀects the assembly of
F-actin that functions as a barrier for the AQP2 traﬃcking
between the apical membrane and the intracellular compart-
ments through the crosstalk with Rho family GTPases. Thus,
SPA-1 binding to AQP2 may reduce the levels of Rap1GTP
that trigger F-actin disassembly in a restricted area, resulting
in the promotion of the AQP2 sorting.
PDZ proteins regulate membrane protein sorting by pro-
viding the molecular link between membrane proteins and
cytoskeletal elements [7,26]. GAPs for small GTPases are
known to be eﬀectors that mediate various signal transduction
pathways. According to the beneﬁts of SPA-1 as a PDZ pro-
tein and a GAP, SPA-1 may regulate protein traﬃcking.
In the present experiments, we have discovered the protein
that regulates AQP2 sorting by binding directly. Our ﬁnding is
the ﬁrst report concerning the interaction between a member of
GAPs and a member of recycling channel proteins, providing a
wider role for GAPs and a novel mechanism for membrane
protein traﬃcking.
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